亚太肠内医疗营养市场预测至 2028 年 - COVID-19 影响和按适应症进行的区域分析(呼吸系统疾病、癌症、COVID-19 后、胃肠道疾病、肝功能衰竭等)、营养类型(补充和单一来源)、形态(粉末、液体和半固体)、产品(标准蛋白饮食、高蛋白饮食、果汁口服营养补充剂等)、分销渠道(医院药房、零售店等)和年龄段[儿童(18 岁以下)和成人(18 岁以上)]

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 220    |    Report Code: BMIRE00027515    |    Category: Life Sciences

Asia Pacific Enteral Medical Nutrition Market

亚太地区肠内医疗营养市场预计将从 2022 年的 10.5741 亿美元增长到 2028 年的 16.4169 亿美元。预计 2022 年至 2028 年复合年增长率为 5.9% 2028.

使用下一代技术进行适当的肠内营养喂养

在肠内喂养中,计算患者的每日和累积能量平衡非常重要,因为它有助于医生根据患者的需要规划喂养路线,降低患者的发病和死亡风险。出院后维持营养供应也很重要。没有适当的技术或设备可用于计算患者的每日和累积能量平衡。研究人员现在专注于使用人工智能(AI)和预测算法来开发可用于处理热量和蛋白质不足以及监测能量平衡的技术。下一代肠内营养喂养技术可用于在 ICU 和 ICU 出院后病房之间建立沟通,以了解营养状况和预测缺陷。可以对患者未吃的医院食物进行分析,以评估能量、蛋白质和维生素的缺乏情况。类似的方法可以克服 ICU 后时期的缺陷。在关键阶段实施下一代基于技术的工具可以帮助确保患者的营养计划和目标得到持续测量、监控和实现。此外,可穿戴数据可以与电子健康记录(EHR)数据集成,包括来自连续测量身体活动和血糖水平的传感器的数据。代谢组学和蛋白质组学领域的不断发展具有评估营养状况、适当调整营养组合以及监测疾病各个阶段进展的潜力。因此,在肠内医疗营养中使用人工智能、预测分析、代谢组学和蛋白质组学以及许多下一代技术来进行适当的喂养,预计将在预测期内为肠内医疗营养市场创造利润丰厚的增长机会。

市场概况

亚太地区是肠内医疗营养增长最快的区域市场,细分为中国、日本、印度、韩国、澳大利亚和亚太地区其他地区。促进这些国家肠内营养市场增长的因素是慢性病患病率的上升以及全国范围内市场参与者的不断增加,从而赋予了肠内营养产品最高的产量。此外,营养领域的支持性政府举措和研究促进了市场增长。

澳大利亚、印度和韩国等国家预计将提供各种增长机会由于医疗保健行业的不断发展。此外,这些国家的政府正在全国范围内加大肠内营养的力度。此外,慢性病发病率的上升以及肠内营养意识的增强可能会在未来几年为市场参与者提供更大的增长机会。

亚太肠内医疗营养市场收入及预测至2028年(百万美元)

亚太肠内医疗营养医疗营养市场细分

亚太肠内医疗营养市场按适应症、营养类型、形式、产品、分销渠道、年龄组和国家进行细分。

根据适应症,亚太肠内医疗营养市场分为呼吸系统疾病、癌症、COVID-19 后、胃肠道疾病、肝功能衰竭等。 2022年,呼吸系统疾病细分市场占据最大份额。根据营养类型,亚太肠内医疗营养市场分为补充来源和单一来源。 2022年,补充剂细分市场占据最大市场份额。根据形式,亚太肠内医疗营养市场分为粉末、液体和半固体。 2022年,半固体细分市场占据最大市场份额。根据产品,亚太肠内医疗营养市场分为标准蛋白饮食、高蛋白饮食、果汁口服营养等。 2022年,标准蛋白质饮食细分市场占据最大市场份额。根据分销渠道,亚太肠内医疗营养市场分为医院药房、零售店和其他药房。 2022年,医院药房细分市场占据最大份额。根据年龄组,亚太肠内医疗营养市场分为儿童(18岁以下)和成人(18岁以上)。 2022 年,成人市场占据最大市场份额。根据国家/地区,市场分为澳大利亚、中国、印度、日本、韩国和亚太其他地区。 2022 年中国将主导市场。雅培实验室; B. 布劳恩梅尔松根股份公司;帝斯曼营养产品股份公司;费森尤斯·卡比股份公司;全球健康产品公司;荷美尔食品公司;明治控股有限公司;雀巢南澳;纽迪希亚;和 Smartfish AS 是该地区肠内医疗营养市场的领先公司。



Asia Pacific Enteral Medical Nutrition Strategic Insights

Strategic insights for Asia Pacific Enteral Medical Nutrition involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-enteral-medical-nutrition-market-strategic-framework.webp
Get more information on this report

Asia Pacific Enteral Medical Nutrition Report Scope

Report Attribute Details
Market size in 2022 US$ 1,057.41 Million
Market Size by 2028 US$ 1,641.69 Million
Global CAGR (2022 - 2028) 5.9%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 适应症
  • 呼吸系统疾病
  • 癌症
  • 新冠肺炎后遗症
  • 胃肠道疾病
  • 肝功能衰竭
By 营养类型
  • 补充和唯一来源
By 形态
  • 粉末
  • 液体
  • 半固体
By 产品
  • 标准蛋白质饮食
  • 高蛋白质饮食
  • 果汁类口服营养补充剂
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • DSM Nutritional Products AG
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Meiji Holdings Co., Ltd.
  • Nestlé S.A.
  • Nutricia
  • Smartfish AS
  • Get more information on this report

    Asia Pacific Enteral Medical Nutrition Regional Insights

    The regional scope of Asia Pacific Enteral Medical Nutrition refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-enteral-medical-nutrition-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Enteral Medical Nutrition Market

    1. Abbott Laboratories
    2. B. Braun Melsungen AG
    3. DSM Nutritional Products AG
    4. Fresenius Kabi AG
    5. Global Health Products, Inc.
    6. Hormel Foods Corporation
    7. Meiji Holdings Co., Ltd.
    8. Nestlé S.A.
    9. Nutricia
    10. Smartfish AS
    Frequently Asked Questions
    How big is the Asia Pacific Enteral Medical Nutrition Market?

    The Asia Pacific Enteral Medical Nutrition Market is valued at US$ 1,057.41 Million in 2022, it is projected to reach US$ 1,641.69 Million by 2028.

    What is the CAGR for Asia Pacific Enteral Medical Nutrition Market by (2022 - 2028)?

    As per our report Asia Pacific Enteral Medical Nutrition Market, the market size is valued at US$ 1,057.41 Million in 2022, projecting it to reach US$ 1,641.69 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Enteral Medical Nutrition Market report typically cover these key segments-

  • 适应症 (呼吸系统疾病, 癌症, 新冠肺炎后遗症, 胃肠道疾病, 肝功能衰竭)
  • 营养类型 (补充和唯一来源)
  • 形态 (粉末, 液体, 半固体)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Enteral Medical Nutrition Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Enteral Medical Nutrition Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific Enteral Medical Nutrition Market?

    The Asia Pacific Enteral Medical Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • DSM Nutritional Products AG
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Meiji Holdings Co., Ltd.
  • Nestlé S.A.
  • Nutricia
  • Smartfish AS
  • Who should buy this report?

    The Asia Pacific Enteral Medical Nutrition Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Enteral Medical Nutrition Market value chain can benefit from the information contained in a comprehensive market report.